AGOMELATINE IN CHILDREN AND ADOLESCENTS WITH MODERATE TO SEVERE MAJOR DEPRESSIVE DISORDER: 2-YEAR OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Falissard, B. [1 ]
Buitelaar, J. K. [2 ,3 ]
Fegert, J. M. [4 ]
Penelaud, P. F. [5 ]
Marx, U. [6 ]
Picarel-Blanchot, F. [7 ]
Arango, C. [8 ]
机构：
[1] Sante Mentale & Sante Publ, Ctr Rech Epidemiol & Sante Populat, INSERM, U018, Paris, France
[2] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Med Ctr, Nijmegen, Netherlands
[3] Karakter Child & Adolescent Psychiat Univ Ctr, Nijmegen, Netherlands
[4] Univ Hosp Ulm, Dept Child & Adolescent Psychiat Psychotherapy, Ulm, Germany
[5] Inst Rech Int Servier, Ctr Therapeut Innovat, Suresnes, France
[6] Servier Forsch & Pharma, Munich, Germany
[7] Global Med & Patient Affairs GMPA, Internal Med & Neuropsychiat, Suresnes, France
[8] Univ Complutense, Hosp Gen Univ Gregorio Maranon, Inst Psychiat & Mental Hlth, IiSGM,Sch Med, Madrid, Spain
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2023年 / 57卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [21] Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Tobias Banaschewski
    Mats Johnson
    Peter Nagy
    Isabel Hernández Otero
    César A. Soutullo
    Brian Yan
    Alessandro Zuddas
    David R. Coghill
    CNS Drugs, 2018, 32 : 455 - 467
  • [22] Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Banaschewski, Tobias
    Johnson, Mats
    Nagy, Peter
    Otero, Isabel Hernandez
    Soutullo, Cesar A.
    Yan, Brian
    Zuddas, Alessandro
    Coghill, David R.
    CNS DRUGS, 2018, 32 (05) : 455 - 467
  • [23] Tofacitinib in patients with moderate to severe chronic plaque psoriasis: 2-year efficacy and safety in an open-label long-term extension study
    Paul, Carle
    Langley, Richard G.
    Valenzuela, Fernando
    Cather, Jennifer
    Gardner, Annie
    Proulx, James
    Tan, Huaming
    Wolk, Robert
    Kaur, Mandeep
    Rottinghaus, Scott
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB278 - AB278
  • [24] Safety and effectiveness of lurasidone in adolescents with schizophrenia: A one-year interim analysis of a 2-year open-label extension study
    Correll, C.
    Tocco, M.
    Goldman, R.
    Pikalov, A.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S127 - S127
  • [25] Effect of lurasidone on cognition in adolescents with schizophrenia: A one-year interim analysis of a 2-year open-label extension study
    Harvey, P. D.
    Goldman, R.
    Tocco, M.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S123 - S123
  • [26] Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-Label Extension Study
    Fernandez, Hubert H.
    Stamler, David
    Davis, Mat D.
    Factor, Stewart A.
    Hauser, Robert A.
    Jimenez-Shahed, Joohi
    Ondo, William G.
    Jarskog, L. Fredrik
    Woods, Scott W.
    LeDoux, Mark S.
    Shprecher, David R.
    Anderson, Karen E.
    NEUROLOGY, 2018, 90
  • [27] 2-year maintenance of response with tralokinumab in moderate-to-severe atopic dermatitis: interim analysis of the ECZTEND open-label extension trial
    Blauvelt, A.
    Lacour, J. -P.
    Toth, D.
    Langley, R.
    Warren, R.
    Pinto, P. Herranz
    Pink, A.
    Simpson, Eric
    Peris, Ketty
    Wollenberg, Andreas
    Le Gjerum
    Fangel, Stine
    Corriveau, Josh
    Schneider, Shannon
    Reich, Kristian
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E143 - E144
  • [28] Dupilumab in Adults With Moderate to Severe Atopic Dermatitis A 5-Year Open-Label Extension Study
    Beck, Lisa A.
    Bissonnette, Robert
    Deleuran, Mette
    Nakahara, Takeshi
    Galus, Ryszard
    Coleman, Anna
    Gherardi, Guy
    Xiao, Jing
    Dingman, Robert
    Xu, Christine
    Avetisova, Elena
    Dubost-Brama, Ariane
    Shabbir, Arsalan
    JAMA DERMATOLOGY, 2024, 160 (08) : 805 - 812
  • [29] Agomelatine as monotherapy for major depression: an outpatient, open-label study
    Pecenak, Jan
    Novotny, Vladimir
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1595 - 1604
  • [30] EFFICACY OF LONG-TERM TREATMENT WITH LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: INTERIM ANALYSIS OF A 2-YEAR OPEN-LABEL EXTENSION STUDY
    DelBello, M. P.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 143 - 144
12345